Published in J Virol on December 01, 1989
RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev (1996) 3.36
Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol Biol Cell (2006) 2.84
Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol (1999) 2.70
Viral subversion of the host protein synthesis machinery. Nat Rev Microbiol (2011) 2.07
Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J Virol (1992) 1.88
Translation of Sindbis virus mRNA: effects of sequences downstream of the initiating codon. J Virol (1994) 1.86
Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol Mol Biol Rev (2000) 1.86
Eukaryotic initiation factor 4GII (eIF4GII), but not eIF4GI, cleavage correlates with inhibition of host cell protein synthesis after human rhinovirus infection. J Virol (1999) 1.72
Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58
Modification of eukaryotic initiation factor 4F during infection by influenza virus. J Virol (1993) 1.48
Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol (1999) 1.43
Stable formation of compositionally unique stress granules in virus-infected cells. J Virol (2010) 1.34
Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J Virol (1992) 1.29
Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol (2001) 1.28
Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage. J Virol (1995) 1.28
Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity. J Virol (1992) 1.25
eIF2alpha kinases GCN2 and PERK modulate transcription and translation of distinct sets of mRNAs in mouse liver. Physiol Genomics (2009) 1.22
Tinkering with translation: protein synthesis in virus-infected cells. Cold Spring Harb Perspect Biol (2013) 1.21
Cap-independent translation initiation in Xenopus oocytes. Nucleic Acids Res (1997) 1.19
Mengovirus leader is involved in the inhibition of host cell protein synthesis. J Virol (1996) 1.18
Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J Virol (1994) 1.12
Adenovirus inhibition of cellular protein synthesis is prevented by the drug 2-aminopurine. Proc Natl Acad Sci U S A (1990) 1.11
Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication. PLoS One (2008) 1.10
Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J Virol (1993) 1.10
A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells. J Virol (1993) 1.07
Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity. J Virol (1995) 1.05
Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. Virology (2008) 1.03
Poliovirus unlinks TIA1 aggregation and mRNA stress granule formation. J Virol (2011) 0.99
Poliovirus switches to an eIF2-independent mode of translation during infection. J Virol (2011) 0.97
Anisomycin and rapamycin define an area upstream of p70/85S6k containing a bifurcation to histone H3-HMG-like protein phosphorylation and c-fos-c-jun induction. Mol Cell Biol (1994) 0.96
Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A. J Virol (2003) 0.94
Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J Virol (1998) 0.94
cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli. J Virol (1991) 0.90
Translation without eIF2 promoted by poliovirus 2A protease. PLoS One (2011) 0.85
Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res (1996) 0.84
Translation of viral mRNA without active eIF2: the case of picornaviruses. PLoS One (2011) 0.83
The alpha subunit of eucaryotic initiation factor 2 is phosphorylated in mengovirus-infected mouse L cells. J Virol (1990) 0.83
The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. J Virol (1996) 0.81
Regulation of a double-stranded RNA modification activity in human cells. Mol Cell Biol (1991) 0.80
Avian reovirus S1133 can replicate in mouse L cells: effect of pH and cell attachment status on viral infection. J Virol (1991) 0.79
Enterovirus Control of Translation and RNA Granule Stress Responses. Viruses (2016) 0.76
The stimulatory effect of actinomycin D on avian reovirus replication in L cells suggests that translational competition dictates the fate of the infection. J Virol (1991) 0.76
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci U S A (1979) 27.20
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78
Phosphorylation of initiation factor elF-2 and the control of reticulocyte protein synthesis. Cell (1977) 6.22
Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol Cell Biol (1985) 4.94
Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A (1978) 4.59
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
Regulation of translation by poliovirus. Adv Virus Res (1987) 4.08
An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis. J Virol (1988) 3.93
Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells. J Biol Chem (1981) 3.41
Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc Natl Acad Sci U S A (1985) 3.09
Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection. J Virol (1987) 3.07
2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science (1988) 2.97
Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis. J Biol Chem (1987) 2.87
The regulation of initiation of mammalian protein synthesis. Prog Nucleic Acid Res Mol Biol (1981) 2.81
Regulation of a protein synthesis initiation factor by adenovirus virus-associated RNA. Nature (1985) 2.80
Regulation of protein synthesis in HeLa cells. 3. Inhibition during poliovirus infection. J Virol (1971) 2.80
Construction and characterization of poliovirus subgenomic replicons. J Virol (1988) 2.69
Mutational analysis of upstream AUG codons of poliovirus RNA. J Virol (1988) 2.55
Translational control by adenovirus: lack of virus-associated RNAI during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis. Proc Natl Acad Sci U S A (1985) 2.53
2B or not 2B: regulation of the catalytic utilization of eIF-2. Cell (1983) 2.32
Poliovirus-induced inhibition of polypeptide initiation in vitro on native polyribosomes. Proc Natl Acad Sci U S A (1976) 2.15
Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02
Heat shock-induced translational alterations in HeLa cells. Initiation factor modifications and the inhibition of translation. J Biol Chem (1984) 1.99
The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol (1989) 1.96
Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J Virol (1984) 1.87
Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J Virol (1989) 1.85
The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation. J Virol (1988) 1.81
The effect of cyclic AMP and related compounds on the control of protein synthesis in reticulocyte lysates. Biochem Biophys Res Commun (1974) 1.74
The cap-binding protein complex in uninfected and poliovirus-infected HeLa cells. J Biol Chem (1987) 1.73
Modification of protein synthesis initiation factors and the shut-off of host protein synthesis in adenovirus-infected cells. Virology (1989) 1.66
Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol Cell Biol (1986) 1.61
Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells. J Virol (1985) 1.51
Effect of poliovirus double-stranded RNA on viral and host-cell protein synthesis. Proc Natl Acad Sci U S A (1974) 1.39
Activation of double-stranded RNA-activated protein kinase in HeLa cells after poliovirus infection does not result in increased phosphorylation of eucaryotic initiation factor-2. J Virol (1987) 1.00
Differential phosphorylation of soluble versus ribosome-bound eukaryotic initiation factor 2 in the Ehrlich ascites tumor cell. J Biol Chem (1982) 0.95
Cloned poliovirus complementary DNA is infectious in mammalian cells. Science (1981) 12.50
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82
The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene (1980) 5.08
Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol (1988) 4.97
Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol (1986) 4.91
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell (1990) 3.70
Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA. J Mol Biol (1981) 3.18
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5'-noncoding region of the viral RNA. Virology (1986) 2.95
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Neutralization of poliovirus by cell receptors expressed in insect cells. J Virol (1990) 2.77
Construction and characterization of poliovirus subgenomic replicons. J Virol (1988) 2.69
Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci U S A (1989) 2.65
Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci U S A (2000) 2.64
Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol (1989) 2.46
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol (1987) 2.36
Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J (1994) 2.03
Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol (1991) 2.00
Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology (1993) 1.97
Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J Virol (1992) 1.94
Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region. J Virol (1988) 1.85
Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J Virol (1989) 1.85
Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J Virol Methods (1993) 1.82
In vitro synthesis of infectious poliovirus RNA. Proc Natl Acad Sci U S A (1985) 1.78
Transformation of a human poliovirus receptor gene into mouse cells. Proc Natl Acad Sci U S A (1986) 1.68
Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies. Virology (1987) 1.67
Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis (1992) 1.66
Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol (1992) 1.65
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol (1995) 1.63
Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J Virol (1994) 1.61
Host range determinants located on the interior of the poliovirus capsid. EMBO J (1991) 1.60
Poliovirus mutants resistant to neutralization with soluble cell receptors. Science (1990) 1.52
Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J Virol (1995) 1.47
Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J Virol (2001) 1.46
Two distinct binding affinities of poliovirus for its cellular receptor. J Biol Chem (2000) 1.45
The polio eradication effort: should vaccine eradication be next? Science (1997) 1.44
Influenza B virus genome: assignment of viral polypeptides to RNA segments. J Virol (1979) 1.43
Cold-adapted poliovirus mutants bypass a postentry replication block. J Virol (1997) 1.42
The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol (1999) 1.38
A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J Virol (1994) 1.37
Defects in nuclear and cytoskeletal morphology and mitochondrial localization in spermatozoa of mice lacking nectin-2, a component of cell-cell adherens junctions. Mol Cell Biol (2000) 1.35
Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol (1990) 1.34
Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase. J Virol (1986) 1.30
Attenuating mutations in the poliovirus 5' untranslated region alter its interaction with polypyrimidine tract-binding protein. J Virol (1997) 1.29
A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol (1992) 1.25
Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J Virol (1989) 1.23
Mutational analysis of the cellular receptor for poliovirus. J Virol (1991) 1.04
Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J Virol (1997) 1.02
An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures. J Virol (2000) 0.95
Isolation of influenza C virus recombinants. J Virol (1979) 0.95
Genetic structure and genetic variation of influenza viruses. Philos Trans R Soc Lond B Biol Sci (1980) 0.92
CD44 is not required for poliovirus replication. J Virol (1997) 0.88
Pattern of undermethylation of the major satellite DNA of mouse sperm. Nucleic Acids Res (1985) 0.88
Persistent echovirus infection of mouse cells expressing the viral receptor VLA-2. Virology (1997) 0.88
Down regulation of poliovirus receptor RNA in HeLa cells resistant to poliovirus infection. J Virol (1991) 0.82
Construction of an infectious cDNA clone of echovirus 6. Virus Res (1992) 0.80
Characterization of mouse lines transgenic with the human poliovirus receptor gene. Microb Pathog (1998) 0.79
Differences in the UV-crosslinking patterns of the poliovirus 5'-untranslated region with cell proteins from poliovirus-susceptible and -resistant tissues. Virology (1997) 0.77
Viral sequences required for neurovirulence of poliovirus. Bioessays (1986) 0.75
Poliovirus vaccines. Biotechnology (1992) 0.75
Studying poliovirus with infectious cloned cDNA. Rev Infect Dis (1984) 0.75